Aigen Investment Management, LP Vertex Pharmaceuticals Inc Transaction History

Aigen Investment Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$392.81 - $485.53 $500,439 - $618,565	1,274 New	1,274 $597,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $1.37 Million - $1.53 Million	4,358 New	4,358 $1.53 Million
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $1.49 Million - $1.66 Million	5,436 Added 432.8%	6,692 $1.94 Million
Q2 2022 Aug 02, 2022	BUY	$234.96 - $292.55 $295,109 - $367,442	1,256 New	1,256 $354,000
Q1 2022 May 05, 2022	SELL	$221.42 - $260.97 $898,743 - $1.06 Million	-4,059 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $967,359 - $1.22 Million	-5,465 Reduced 57.38%	4,059 $867,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $3.74 Million - $4.18 Million	-20,607 Reduced 68.39%	9,524 $1.73 Million
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $5.65 Million - $6.66 Million	30,131 New	30,131 $6.08 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $4.33 Million - $5.77 Million	-20,899 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$255.65 - $303.1 $2 Million - $2.37 Million	-7,804 Reduced 27.19%	20,899 $5.69 Million
Q2 2020 Aug 10, 2020	BUY	$225.48 - $295.8 $335,739 - $440,446	1,489 Added 5.47%	28,703 $8.33 Million
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $1.61 Million - $1.99 Million	8,037 Added 41.91%	27,214 $6.48 Million
Q4 2019 Feb 04, 2020	BUY	$166.71 - $223.91 $3.2 Million - $4.29 Million	19,177 New	19,177 $4.2 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.